[Informed consent, QOL and cost benefit in the treatment of lung cancer].
Ethical issues, including informed consent, quality of life and cost/benefit, are discussed. Informed consent is not only ethical discipline but also legal concept. It is important to know how and when to disclose the truth. Training and experience are critically important to acquire clinical-behavioral skill. Physicians also should know some pitfalls, including patient's right to decline information especially in terminal situation. Quality of life(QOL) is an important concept for medical practice in the treatment of lung cancer. Although several instruments have been developed for QOL measurement, poor compliance and feedback to patient care, and meaningless domains are criticized. Disease related symptom(DRS) and cost analysis should be used in future clinical trials of lung cancer.